Schrödinger to Present at the Jefferies 2019 Global Healthcare Conference

About Schrödinger

Schrödinger has a substantial and growing global business, licensing its industry-leading computational platform to pharmaceutical, biotechnology, chemical, and electronics companies to accelerate R&D in both drug discovery and materials design. Schrödinger has built a robust pipeline of therapeutic assets, held both internally and in partnerships, and has co-founded leading biotech companies, including Nimbus Therapeutics and Morphic Therapeutic. Schrödinger’s significant and ongoing investment in basic research continues to drive advances in its computational platform. Founded in 1990, Schrödinger has approximately 400 employees in its New York City headquarters and around the world. Visit schrodinger.com for more information.

View source version on businesswire.com: https://www.businesswire.com/news/home/20190530005871/en/